Kidney failure related to broad-spectrum antibiotics in critically ill patients: secondary end point results from a 1200 patient randomised trial

JUS Jensen, L Hein, B Lundgren, MH Bestle, T Mohr… - BMJ open, 2012 - bmjopen.bmj.com
Objectives To explore whether a strategy of more intensive antibiotic therapy leads to
emergence or prolongation of renal failure in intensive care patients. Design Secondary …

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial

L Bouadma, CE Luyt, F Tubach, C Cracco, A Alvarez… - The Lancet, 2010 - thelancet.com
Background Reduced duration of antibiotic treatment might contain the emergence of
multidrug-resistant bacteria in intensive care units. We aimed to establish the effectiveness …

Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study

DM Roberts, JA Roberts, MS Roberts, X Liu… - Critical care …, 2012 - journals.lww.com
Objectives: In critically ill patients receiving continuous renal replacement therapy, we aimed
to assess the variability of antibiotic trough concentrations, the influence of effluent flow rates …

Rational use of antibiotics in an intensive care unit: a retrospective study of the impact on clinical outcomes and mortality rate

M Ali, H Naureen, MH Tariq, MJ Farrukh… - Infection and drug …, 2019 - Taylor & Francis
Background Intensive care units (ICUs) are specialized units where patients with critical
conditions are admitted for getting specialized and individualized medical treatment. High …

Antibiotic dosing in critically ill patients with acute kidney injury

RF Eyler, BA Mueller - Nature Reviews Nephrology, 2011 - nature.com
A common cause of acute kidney injury (AKI) is sepsis, which makes appropriate dosing of
antibiotics in these patients essential. Drug dosing in critically ill patients with AKI, however …

An integral pharmacokinetic analysis of piperacillin and tazobactam in plasma and urine in critically ill patients

E Wallenburg, R Ter Heine, JA Schouten… - Clinical …, 2022 - Springer
Abstract Background and Objectives Although dose optimization studies have been
performed for piperacillin and tazobactam separately, a combined integral analysis is not yet …

Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy

M Ulldemolins, S Vaquer, M Llauradó-Serra, C Pontes… - Critical care, 2014 - Springer
Although early and appropriate antibiotic therapy remains the most important intervention for
successful treatment of septic shock, data guiding optimization of beta-lactam prescription in …

Antibiotic exposure profiles in trials comparing intensity of continuous renal replacement therapy

SM Jang, MP Pai, AR Shaw, BA Mueller - Critical Care Medicine, 2019 - journals.lww.com
Objectives: To determine whether the probability of target attainment over 72 hours of initial
therapy with beta-lactam (cefepime, ceftazidime, piperacillin/tazobactam) and carbapenem …

Drug regimens of novel antibiotics in critically ill patients with varying renal functions: a rapid review

J Gorham, FS Taccone, M Hites - Antibiotics, 2022 - mdpi.com
There is currently an increase in the emergence of multidrug-resistant bacteria (MDR)
worldwide, requiring the development of novel antibiotics. However, it is not only the choice …

The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary?

S Blot, J Lipman, DM Roberts, JA Roberts - Diagnostic microbiology and …, 2014 - Elsevier
Optimal dosing of antimicrobial therapy is pivotal to increase the likelihood of survival in
critically ill patients with sepsis. Drug exposure that maximizes bacterial killing, minimizes …